Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD

NCT00370370 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Neovascular Age-Related Macular Degeneration

Interventions

DRUG: bevacizumab
DRUG: bevacizumab + triamcinolone acetonide

Sponsor

Shahid Beheshti University of Medical Sciences